TaiGen Biopharmaceuticals Holdings Limited (TPEX: 4157)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
14.50
+0.55 (3.94%)
Sep 10, 2024, 1:30 PM CST

TaiGen Biopharmaceuticals Holdings Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
235.16136.73-237.16775.62-404.82-295.69
Upgrade
Depreciation & Amortization
25.627.4828.4628.7430.8633.54
Upgrade
Other Amortization
0.130.130.090.120.570.78
Upgrade
Loss (Gain) From Sale of Assets
---0.08-0.01-
Upgrade
Asset Writedown & Restructuring Costs
--12.06-2.92-
Upgrade
Loss (Gain) From Sale of Investments
-173.86-165.22-0.3-0.08-0.43-151.89
Upgrade
Loss (Gain) on Equity Investments
---23.24113.04133.96
Upgrade
Stock-Based Compensation
36.0725-4.9940.0314.44-
Upgrade
Provision & Write-off of Bad Debts
7.67.6----
Upgrade
Other Operating Activities
-67.841.22-60.8840.07-20.9431.39
Upgrade
Change in Accounts Receivable
-3.11.83260.02-272.8-5.440.33
Upgrade
Change in Inventory
-32.42-18.753.29-4.35-7.133.16
Upgrade
Change in Accounts Payable
0.660.66-17.3310.49-1.49-31.6
Upgrade
Change in Unearned Revenue
-0.15-0.15-0.16-44.4144.06-0.32
Upgrade
Change in Income Taxes
---26.290.29-2.77
Upgrade
Change in Other Net Operating Assets
25.15-9.05-4.37-2.68-2.26-15.93
Upgrade
Operating Cash Flow
-196.937.46-21.27629.07-242.1-342.52
Upgrade
Capital Expenditures
-1.04-3.89-3.39-10.24-5.46-3.87
Upgrade
Sale of Property, Plant & Equipment
---0.110.01-
Upgrade
Sale (Purchase) of Intangibles
-3.47-3.51-4.07-1.6-2.95-1.2
Upgrade
Investment in Securities
256.82138.44-81.62-298.07216.76315.06
Upgrade
Other Investing Activities
21.514.424.133.737.7412.21
Upgrade
Investing Cash Flow
273.81145.46-84.95-306.07216.1322.2
Upgrade
Short-Term Debt Issued
--3--30
Upgrade
Total Debt Issued
--3--30
Upgrade
Short-Term Debt Repaid
--3---30-
Upgrade
Long-Term Debt Repaid
--16.99-17.99-18.61-19.07-20.97
Upgrade
Total Debt Repaid
-15.81-19.99-17.99-18.61-49.07-20.97
Upgrade
Net Debt Issued (Repaid)
-15.81-19.99-14.99-18.61-49.079.03
Upgrade
Issuance of Common Stock
----0.021.13
Upgrade
Other Financing Activities
-1.6-1.14-0.85-0.24-0.6-1.03
Upgrade
Financing Cash Flow
-17.4-21.12-15.84-18.85-49.659.13
Upgrade
Foreign Exchange Rate Adjustments
1.3-0.250.24-0.070.25-0.66
Upgrade
Net Cash Flow
60.77131.55-121.82304.08-75.4-11.85
Upgrade
Free Cash Flow
-197.973.57-24.66618.83-247.56-346.39
Upgrade
Free Cash Flow Margin
-132.46%2.90%-68.06%47.80%-1056.95%-1705.17%
Upgrade
Free Cash Flow Per Share
-0.270.00-0.030.86-0.35-0.48
Upgrade
Cash Interest Paid
1.141.140.850.240.61.03
Upgrade
Cash Income Tax Paid
9.839.8332.2272.513.23-
Upgrade
Levered Free Cash Flow
-58.59-84.5157.08366.39-111.98-193.26
Upgrade
Unlevered Free Cash Flow
-57.59-83.857.61366.55-111.61-192.62
Upgrade
Change in Net Working Capital
4.5719.82-215.06252.68-43.0148.67
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.